Evaluation of Early Changes Visible to the Diffusion MRI in Response to Two Years of Treatment With Tysabri in Patients With Multiple Sclerosis

NCT02904876 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis

Interventions

RADIATION: Diffusion Magnetic Resonance Imaging at 6 months

Sponsor

University Hospital, Strasbourg, France